throbber
JOURNAL OF BIOMOLECULAR SCREENING
`Volume 6 Number 6 2001
`© The Society for Biomolecular Screening
`
`High Density Miniaturized Thermal Shift Assays as a
`General Strategy for Drug Discovery
`
`MICHAEL W PANTOLIANOt EUGENE C PETRELLA JOSEPH D KWASNOSKI
`VICTOR S LOBANOV JAMES MYSLIK EDWARD GRAF TED CARVER ERIC ASEL
`BARRY A SPRINGER PAMELA LANE and FR SALEMME
`
`ABSTRACT
`
`More general and universally applicable drug discovery assay technologies
`are needed in order to keep pace with
`chemistry and genomicsbased target generation Ligandinduced conforma
`the recent advances in combinatorial
`tional stabilization of proteins is a well understood phenomenon in which substrates inhibitors cofactors and even
`other proteins provide enhanced stability to proteins on binding This phenomenon is based on the energetic cou
`pling of the ligandbinding and protein melting reactions In an attempt
`to harness these biophysical properties for
`drug discovery fully automated instrumentation was designed and implemented to perform miniaturized fluores
`cence based thermal shift assays in a microplate format for the high throughput screening of compound libraries
`Validation of this process and instrumentation was achieved by investigating ligand binding to more than 100 pro
`tein targets The general applicability of the thermal shift screening strategy was found to be an important advan
`tage because it circumvents the need to design and retool new assays with each new therapeutic target Moreover
`the miniaturized thermal shift assay methodology does not require any prior knowledge of a therapeutic targets
`ideally suited for the quantitative high throughput drug screening and evaluation of targets de
`function making it
`rived from genomics
`
`INTRODUCTION
`
`CHALLENGE
`
`CURRENTLY
`
`facing conventional high
`
`AMAJOR
`throughput screening drug discovery methodologies is the
`for the ex
`to rapidly judge relative binding affinities
`ability
`panding numbers of new compounds derived from combinato
`libraries Compounding this task is the recent
`chemical
`flood of new therapeutic targets that have become available
`efforts in both human and
`in genomicsbased
`from advances
`microbial organisms Moreover many of the targets derived
`from genomics have unknown functions12 andor unknown in
`vivo ligands ie orphan receptors34 making conventional as
`say development and drug screening problematic Therefore it
`has become increasingly apparent that more general and uni
`versally applicable assays are needed in order to scale with the
`exponential growth of diverse compounds and targets Some
`examples of general assay strategies have begun to appear
`in
`
`the literature5 many of which employ electron spray mass spec
`trometry as the ligandbinding detection system67
`Thermal shift assays have many biophysical attributes that
`satisfy the requirements of a general cross target drug discov
`stabilization of pro
`conformational
`ery assay Ligandinduced
`teins is a well understood phenomenon in which substrates in
`hibitors cofactors metal
`analogs of natural
`ions synthetic
`ligands and even other proteins provide enhanced
`stability to
`proteins on binding811 This phenomenon is based on the en
`ergetic coupling of the ligandbinding and receptor melting re
`actions as depicted in Figure 1 This energetic linkage results
`in the midpoint for thermally in
`in liganddependent
`changes
`for the ligandreceptor complex relative
`duced melting curves
`to the uncomplexed receptor ATm that are directly propor
`to the ligand binding affinity Ka Traditionally thermal
`shift assays have been conducted
`using differential scanning
`calorimeters DSCs that monitor the change
`in heat capacity
`
`tional
`
`rial
`
`3 Dimensional Pharmaceuticals Inc Exton PA
`Innovative Research SBIR Grant R43 GM52786 Phases I
`Supported in
`part by Small Business
`General Medical Sciences at the National
`Institutes of Health
`Inc Cambridge MA
`
`IPresent address Millennium Pharmaceuticals
`
`II 19951998 from the National
`
`Institute of
`
`429
`
`from the SAGE Social Science Collections All Rights Res
`
`BioRad Exhibit 2008
`IPR201700055
`Page 1 of 12
`
`

`

`430
`
`PANTOLIANO ET AL
`
`IMO
`
`Folded
`
`Molten
`
`Globule
`
`unfolded
`
`with 1gartcl Bowl
`
`FIG 1 Energetics of ligandinduced conformational stabilization of proteins The energetics of thermal shift assays is based on hg
`and dependent receptor stabilization as monitored by ATT measurements
`complexes rel
`for the melting transitions of ligandreceptor
`stabilization is directly related to the ligand binding affinity AGbind because
`receptor This ligandreceptor
`ative to the uncomplexed
`of the thermodynamic linkage between the ligandreceptor binding and ligandreceptor melting free energy functions AGbind and AEI
`for most
`the molten globule is the first state encountered during protein phase transitions5052
`respectively
`is generally believed that
`proteins and the energetics depicted here reflect this phenomenology
`
`It
`
`undergo temperature induced melting
`transi
`as proteins
`tions812 In addition biophysical methods that employ tem
`instrumentation that measures tem
`perature regulated optical
`and
`in absorbance fluorescence
`
`perature dependent
`changes
`circular dichroism have also been historically used to perform
`thermal shift assays1315
`In order
`
`the nearly universal physicochemical
`to exploit
`properties of ligandinduced
`stabilization of proteins for appli
`cations in drug discovery we have miniaturized the thermal
`shift assay for use in a high density microplate format The val
`idation of this miniaturized thermal shift process along with
`the implementation of the instrumentation and software is the
`subject of this report
`
`EXPERIMENTAL PROCEDURES
`
`Proteins
`
`The human a estrogen receptor ESR was purchased from
`PanVera Madison WI Bacteriorhodopsin H halobium
`was purchased from Sigma Chemical Co St Louis MO
`Human a thrombin was purchased from Enzyme Research
`Labs South Bend IN Bovine liver dihydrofolate
`reductase
`DHFR was purchased from Sigma The extracellular do
`mains of the fibroblast growth factor receptor 1 DIIDIII
`FGFR11 were cloned from a human placenta library and ex
`
`pressed as a secreted protein from HEK293E cells details to
`be described elsewhere The PilD enzyme a leader peptidase
`from Pseudomonas aeruginosa
`and an Nmethyltransferase
`from Wim Hol of the University of Wash
`was a generous gift
`ington Seattle
`
`Fluorescent
`
`dyes
`
`dyes 1anilinonaphthalene8
`
`The environmentally sensitive
`sulfonic acid 18ANS 26ANS 2ptoluidiny1napthalene
`6sulfonic acid 26TNS and the 54dimethylaminopheny1
`24phenyloxazole family of dyes Dapoxyl° sulfonic acid
`from Molecular Probes Eugene OR Envi
`were purchased
`ronmentally sensitive dyes are fluorophores that have low quan
`turn yields low QY in solvents with high dielectric constants
`such as water but are highly fluorescent high QY in solvents
`with low dielectric constants such as ethanol and dioxane16
`Examples of these dyes include the napthylamine sulfonic acids
`such as 18ANS 26ANS and 26TNS and also the Dapoxyl
`family of dyes17 They can be used as extrinsic probes of un
`folded or melted proteins because the dyes partition themselves
`into the melted protein or molten globule states that have low
`dielectric properties resembling those of organic solvents The
`result is a large increase in fluorescence for the extrinsic dye
`as a function of protein thermal melting These dyes are ex
`region and have emission in the vis
`cited in the near ultraviolet
`
`ible region 460530 nm
`
`BioRad Exhibit 2008
`IPR201700055
`Page 2 of 12
`
`

`

`APPLICABILITY OF THERMAL SHIFT ASSAYS FOR DRUG DISCOVERY
`
`431
`
`Microplate thermal shift assay process
`and instrumentation
`
`The proteindye solutions were first dispensed into each well
`of a 384 well microplate polystyrene conical well microplates
`MJ Research Inc Waltham MA in equal 25 or 50 pt
`aliquots Then an equal volume of test compound solution typ
`in 510 DMSO were dispensed
`ically 100200 aull
`into
`each well to yield test ligands at 50100 uM in an assay volume
`of 50100 µL The resulting amount of protein utilized for an
`is 025050 µgwell 15 AM for
`average therapeutic
`an 300kDa protein or 100200 Agplate depending
`on the
`volume chosen Finally a small volume of mineral oil was added
`to each well
`to eliminate evaporation Reference
`control wells
`ligands containing the appropriate amount of DMSO
`no test
`were distributed on the 384 well plate usually in rows 12 and
`24 The plates were subsequently heated in the custom designed
`
`target
`
`microplate thermal shift assay instrument Fig 2 which auto
`matically monitored the complete thermal melting of the proteins
`device CCD camera detection of changes
`through closedcircuit
`in fluorescence
`for the extrinsic environmentally sensitive fluo
`rophore A Genesis 5000 liquid handling robot Tecan Group
`Ltd Mannedorf Switzerland controlled the fluidics dispensing
`of all
`reagents to assay microplates
`
`RESULTS
`
`Microplate thermal shift process and instrumentation
`
`A fully automated miniaturized
`thermal
`shift assay
`that
`works in a high density microplate format was designed and
`implemented so that 384 protein melting transitions are simul
`instruments were con
`taneously processed Pilot and beta
`
`A
`
`Data
`
`Analysis
`Computer
`
`Thermally
`Controlled
`Sample
`Plate
`
`B
`
`Fluorescent
`
`Reporter
`Low QY in High
`Dielectric Media
`ie 1120
`
`hVA
`
`hvF
`
`Heat
`
`T
`
`AG fold
`
`Native Protein
`
`Melted Protein
`Molten Globule
`
`Fluorescent
`
`Reporter
`High QY in Low
`Dielectric Medium
`
`FIG 2 A Microplate thermal shift
`instrumentation The hardware employed for this study utilized a noncooled CCD imaging camera
`that automatically captured the fluorescence changes resulting from the extrinsic dyes that correspond to the thermal melting transitions of
`proteins as they were simultaneously heated on a computer controlled heating block Microplate heating occurred for 1 to 3 min intervals
`in 010 to 50°C increments for any temperature range between 25° and 99°C The CCD images were collected at each designated timetem
`for analysis at the end of the temperature range Typically microplate images were
`perature point and then stored on a personal computer
`collected at 2040 temperature points Microplate well towell temperature uniformity was controlled to yield protein melting temperatures
`that did not exceed ±025°C for all 384 wells in the absence of ligands Epiillumination from long wave
`Tni with standard deviations
`light and a selectable band pass filter allowed the desired fluorescence emission wave
`lengths to reach the CCD camera B Fluorescence based detection of thermal phase transitions in proteins
`lamps provided
`the excitation
`length ultraviolet
`
`BioRad Exhibit 2008
`IPR201700055
`Page 3 of 12
`
`

`

`432
`
`in 15 h or 6000 as
`structed to perform 384 assays
`saysday and are described in the legend to Figure 2A
`The miniaturized thermal shift assay process begins with a
`purified therapeutic protein 75 pure sample at 100
`µgmL in a suitable buffer near neutral pH The protein solu
`tion is then made 100 AM in an environmentally
`sensitive flu
`orescent dye and dispensed into each well of a 384 well mi
`croplate in equal 25 or 50 AL aliquots The monitoring of
`was accomplished
`miniaturized thermal
`phase
`through the use of environmentally
`sensitive fluorescent dyes
`as depicted in Figure 2B A more detailed description of the
`microplate thermal shift process together with the attending
`hardware and software is found in Experimental Procedures
`and elsewhereI820
`
`transitions
`
`Validation studies
`
`and the instrumentation was at
`Validation of this process
`tempted by investigating ligand binding to more than 100 model
`and therapeutic target proteins The following subset was se
`lected from these model systems to illustrate the utility of minia
`turized thermal shift assays for diverse classes of proteins
`
`ceptors
`
`Nuclear hormone receptors ESR The nuclear hormone re
`are a superfamily of ligandactivated DNA binding
`transcription factors ESR is the prototype member of this class
`of receptors involved in the regulation of eucaryotic gene ex
`pression and affecting cellular proliferation and differentiation
`is composed of several do
`tissues2I This receptor
`in target
`for hormone binding22 DNA binding23 and
`mains important
`activation of transcription
`The thermal melting transition for ESR was observed to be at
`445°C in the absence of ligands but was increased to 498°C in
`the presence of the known antagonist tamoxifen Fig 3A Good
`agreement was found for the binding affinity measurement made
`by the miniaturized thermal shift assay Kd = 11 uM and that
`reported in the literature IC50 = 042 0424
`Often the pretransitional and posttransitional baselines yt and
`Yu respectively for the well containing the ligand do not match
`those for the control well This discrepancy has three compo
`nents 1 optical effects 2 liquid handling variation and 3
`quenching of signal as a result of the ligand The optical effects
`are derived from the limitations of using a CCD camera with epi
`illumination There are optical edge effects
`that result from the
`lens of the camera and there are optical perspective
`effects
`the fluorescence mea
`caused by the depth of the wells so that
`sured for wells near
`the middle of the plate is larger than that
`measured near the edges In addition the epiillumination yields
`variable excitation light across the plate which results in vari
`across the CCD camera chip can
`able emission Nonuniformity
`also contribute to the observed variability
`in the pre and post
`transitional baselines The liquidhandling variation introduces
`small differences in volumes of reagents that result in differences
`in observed absolute fluorescence
`intensity Also introduction of
`bubbles during reagent delivery will change the absolute fluo
`rescence intensity derived from different wells Some degree of
`quenching of the fluorescence
`signal derived from the environ
`mentally sensitive dyes occurs
`for a subset of test compounds
`However
`the observed
`variations in absolute fluorescence
`sig
`nal are not a problem for these miniaturized thermal shift assays
`
`PANTOLIANO ET AL
`
`because both the pre and posttransitional baselines yf and Yu
`are measured independently for each well Consequently the crit
`ical thermal melting parameters Tm and Aliu for each well were
`also determined independently within the intrawell boundaries
`of yf and Yu see Eqn 3 in the Appendix
`
`Growth factor and cytokine receptors FGFR1 The FGFR
`1 extracellular domains DIIDIII FGFR I have been shown
`for ligandbinding interactions2527 The
`to be important
`known ligand pentosan polysulfate a sulfated oligosaccharide
`was found to increase the Ti by 25°C Fig 3B which corre
`sponds to a Kd of 55 AM at 25°C when calculated using Equa
`tion 3 see Appendix This is in good agreement with a re
`ported Kd of 11 AM for this ligand measured using isothermal
`titration calorimetry27
`
`Integral membrane proteins The utility of the miniaturized
`thermal shift assay strategy as a drug discovery tool for the in
`tegral membrane protein class was demonstrated with the fol
`lowing examples
`
`The enzyme PilD is
`PILD FROM PSEUDOMONAS AERUGINOSA
`enzyme with two catalytic ac
`a putative fivetransmembrane
`a leader peptidase and an Nmethyltransferase
`tivities
`activity
`that are essential for the proper processing of the type IV pili
`of many gram negative
`proteins expressed on the surface
`The results for the miniaturized thermal shift
`pathogens2829
`assay of ligands binding to PilD are shown in Figure 3C The
`activity cofactor SadenosylLmethionine
`Nmethyltransferase
`was found to increase the Tm by 11°C which corresponds to
`a binding affinity of Kd = 900 LtM This is in good agreement
`with the Kd of 300 AM previously measured using a ra
`dioactive competition assay
`
`BACTERIORHODOPSIN
`The seventransmembrane protein bac
`teriorhodopsin is a light driven proton pump from bacterial pur
`ple membranes and is commonly used as a model
`for struc
`of G proteincoupled
`turefunction
`studies
`receptors
`GPCRs31 The form of bacteriorhodopsin with retinal cova
`lent binding to Lys 216 was reconstituted in nonionic deter
`gents and investigated for its compatibility with the miniatur
`ized thermal shift process The melting transition for
`this
`to occur at 733°C as
`receptorligand complex was observed
`shown in Figure 3D
`
`natorial
`
`Screening of combinatorial
`libraries directed at the serine
`protease human a thrombin A series of seven focused combi
`libraries directed against the catalytic site of the serine
`protease a human thrombin were first assayed using a spec
`trophotometric enzyme assay and then compared with results
`
`One of four different
`receptors FGFR1 through FGFR425 that bind
`fibroblast growth factors a family of 18 related polypeptides FGF I through
`FGF1826 with broad mitogenic and cell survival activities These recep
`tors have been demonstrated
`to be important for embryonic development
`angiogenesis and wound healing in adults
`The enzymatic assays employ spectrophotometric substrates
`such as
`succinylAlaAlaProArgpnitroanilide
`which releases the colored prod
`uct pnitroanilide on hydrolysis
`The enthalpy measurement
`in the miniaturized thermal shift assay is
`of a Vant Hoff enthalpy determination
`the equivalent
`
`BioRad Exhibit 2008
`IPR201700055
`Page 4 of 12
`
`

`

`APPLICABILITY OF THERMAL SHIFT ASSAYS FOR DRUG DISCOVERY
`
`433
`
`a Tm = 55 5 A5
`o Tm = 58O B6
`
`Native D11 DlII FGFR11
`T = 555 °C
`
`on
`
`Da
`
`90
`
`e ad°u3Lia12
`ail 1
`
`csit
`
`o z°ciFt4ba
`
`7
`
`100 uM Pentosan Polysulfate
`AT tx 25°C
`
`50
`
`80
`
`70
`
`80
`
`80
`
`Temperature
`
`1
`
`4T
`
`Tm = 733
`
`Native Bacteriorhodopsin
`T= 733 °C
`
`A
`
`5500
`
`5000
`
`4500
`
`4o00
`
`£3500
`
`3000
`
`2500
`
`2000
`
`o Tm = 445 All
`o Tm = 498A6
`
`Native Estrogen
`Receptor
`T= 445 °C
`
`+ LJrovivr
`
`arrffsTr
`
`+++++
`
`3dirjalb+++++
`
`+++
`+++
`
`++
`
`Ya1
`
`lti
`
`I
`
`r3
`
`50 µM Tamoxifen
`AT = 53 °C
`
`25 3 35
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`70
`
`75
`
`Temperature
`
`3400
`
`3200
`
`3003
`
`2000
`
`au
`
`2400
`
`2000
`
`1800
`
`0 Tm = 497 Al
`0 Tm = 508 A2
`
`Native P110
`Tin = 497 °C
`
`11200
`
`11000
`
`113300
`
`1 10600
`
`10400
`
`10200
`
`10000
`
`9800
`
`100 mM SAdenosylLMethionine
`Arm = 11 °C
`
`11000
`
`10000
`
`9000
`
`18000
`g
`
`7003
`
`60001
`
`5000
`
`40001
`
`35
`
`ill
`
`45
`
`40
`
`45
`
`60
`
`65
`
`70
`
`40
`
`50
`
`60
`
`70
`
`BO
`
`90
`
`100
`
`Temperature
`
`Temperature
`
`FIG 3 Miniaturized thermal shift assay results for diverse classes of enzymes and receptors A Ligand binding to the human a es
`trogen receptor The estrogen receptor was diluted into 50 mM Tris pH 80 80 mM KC1 16 glycerol 10 mM EDTA 10 sodium
`2 mM dithiothreitol
`and 10 mM MgC12 buffer which also contained
`100 104 of the fluorophore Dapoxyl sulfonic acid
`vanandate
`using the instrumentation described Figure 2 The known antagonist
`Fluorescence
`intensity was measured as a function of temperature
`tamoxifen was present at 50 pM and the final assay volume was 100 AL The solid lines through each of the data sets were fit using
`Equation 1 The binding affinity IQ at 25°C was calculated using Equation 3 and was found to be 11 iuM for tamoxifen An IC50 of
`042 iuM for tamoxifen was previously measured by fluorescence polarization24 B Ligand binding to fibroblast growth factor recep
`tor1 Miniaturized thermal shift assay data were obtained for DIIDIII FGFR1 in the presence and absence of ligands The mid
`point for the unfolding transition in the absence of ligands was observed to be 555°C while a known ligand pentosan polysulfate was
`the same conditions The calculated Kd at 25°C was found to be 55 cM Eqn 3
`observed to give a 25°C increase in Tn under
`which compares favorably with the Kd of 11 uM measured through isothermal titration calorimetry The buffer conditions for the as
`says were 50 mM phosphate buffered saline with 40 mM sodium citrate pH 72 10 mM MgC12 2 mM EDTA and 2 glycerol C
`enzyme PilD an example of an integral membrane protein Miniaturized thermal shift assays were
`Ligand binding to the processing
`performed for PilD in the presence and absence of ligands The melting transition in the absence of ligands 100 mM HEPES pH 751
`and 200 mM NaC1 in 123 mM noctyl6oglucopyranoside 05 CMCH20 was observed to have a Tm of 497°C The known
`100 mM is a cofactor
`for the methyl transferase activity of this enzyme and was observed to give
`ligand SadenosylLmethionine
`to a calculated Kd of 900 mM at 25°C Eqn 3 and compares
`a 11°C increase in Tm This corresponds
`favorably with the Kd of 500
`mM reported in the literature The assays were performed as described above with 2 Agwell PilD D Bacteriorhodopsin an example
`of a seventransmembrane protein Miniaturized thermal shift assays were performed for the retinal bound form of bacteriorhodopsin
`from H halobium The protein was solubilized in 5 mM Na0Ac pH 50 buffer containing 64 mM nnonylBDglucopyranoside
`CMCH20 The melting transition for this retinal bound covalent complex was observed to have a Tn of 733°C The assays were
`performed as described above
`
`BioRad Exhibit 2008
`IPR201700055
`Page 5 of 12
`
`

`

`434
`
`PANTOLIANO ET AL
`
`obtained using the miniaturized thermal shift process Fig 4
`The seven focused
`libraries consisted of seven 96 well plates
`synthesized in sequential order There were 213 hits out of the
`original 665 compounds with binding affinities that span 35
`orders of magnitude
`The results from the miniaturized thermal shift assay were
`found to correlate with the results obtained through the enzy
`to the slope =
`matic assay as demonstrated by the reasonable fit
`10 line for the loglog plot The deviation of the data from a
`fit can come from a number of sources the first of which
`
`perfect
`
`is the time interval 6 months between the enzyme and ther
`
`mal shift assays Time dependent
`for some labile li
`changes
`for some differences between the two meth
`gands could account
`ods Another source of some of the deviation may come from
`the range of ligandbinding enthalpies HL = 00 to 250
`kcalmol one might expect for an assortment of different
`li
`gands binding to a given target For examples of compounds
`that have binding affinities that are entropically driven see refs
`12 and 32 This potential assortment
`for ligandbinding en
`thalpies translates into a range for the calculated Ka at T for
`any given ligand when estimated using Equation 3 see Ap
`pendix For example the use of thrombin a ligand that yields
`a AT of 20°C results in a calculated Ka at 37°C of 85 X 105
`when AHL = 00 Eqn 3 while a ligand with AHL = 250
`
`kcalmol yields a calculated Ka at 37°C of 71 X 106 Thus
`in the case of thrombin a 10 fold range in the estimated Ka is
`possible for a given value of ATa which is consistent with the
`variation in Figure 4 Finally there could be a small
`observed
`subset of compounds that that interact with both the native and
`
`if
`
`the ligand
`
`unfolded forms of thrombin thereby resulting in smaller T
`determinations and smaller Ka than expected
`bound only to the native form of thrombin
`Data analysis for these screening experiments was simplified
`using a software interface that graphically displays the com
`puted A T determinations for all 384 wells of the microplate
`thermal shift assay as shown in Figure 5 The results for one
`of the library plates Plate 6 screened against
`thrombin is
`shown using an adjustable gradient color code for LITa mea
`sured for each wellthe more positive the
`TT for an indi
`vidual compound the more deeply redshaded the well White
`signifies little or no change in Tn compared with a control T0
`in which no compounds are present Thus hits can be visually
`identified and ranked by color and bar graph or alternatively
`they may be listed in tables that show the ATm values and es
`timated binding affinities Ka values for all 384 wells not
`shown More details concerning the data analysis software
`tools are located in the Appendix
`The software interface that graphically displays the computed
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`Log 1K1
`
`37°C Enzyme Assay
`
`10
`
`©37°CMiniaturizedThermalShift
`
`Ka
`
`Log
`
`ial
`
`libraries directed at
`
`assay
`
`FIG 4 Screening of focused combinatorial
`site of human a thrombin Seven focused combinator
`libraries directed at the catalytic
`site of human thrombin were first assayed by a conventional
`the catalytic
`enzymatic spectrophotometric
`and then compared with the results obtained using the miniaturized thermal shift process The seven focused libraries consisted of seven
`96 well plates 1 through 7 synthesized
`red diamonds = plate 1 blue boxes = plate 2 magenta boxes = plate 3
`in sequential order
`cyan triangles = plate 4 brown circles = plate 5 green diamonds = plate 6 black triangles = plate 7 The results were plotted in a
`loglog format for direct comparison of the extent
`to which the two different assay measurements are consistent The solid line of slope
`10 represents a perfect match for the two methods of analysis Thrombin was present at 10 AM in 50 mM Hepes pH 75 and 01 M
`NaCl and the Dapoxyl sulfonic acid was present at 100 AM Excitation of the fluorophore was effected using a long wavelength ul
`that allowed 500 to 530nm wavelength
`lamp and the emission was filtered through a bandpass filter
`to pass to the
`of 17 lt14
`CCD camera The compounds
`from the focused libraries were present at a final concentration
`
`traviolet
`
`light
`
`BioRad Exhibit 2008
`IPR201700055
`Page 6 of 12
`
`

`

`APPLICABILITY OF THERMAL SHIFT ASSAYS FOR DRUG DISCOVERY
`
`435
`
`1
`
`Hrrrrrnrr
`
`firtif14 44 10 17 18
`2 3 4 1 6 71$ V
`A lir 71171111711111111Tur 1701
`trrFrErniorrrrlrttatrrStrti
`c EFEEFFT1111111EEFFEIEFEll
`rrr711111rrriltrirrrrarrrrilrr
`F rrrrnrigarrrrnrrrruristrrr
`srrEarrinrrrrFrnorrnrrirn
`itrrrrrrrrrruriErrprrrrr
`Jrnrrnrrnrrnrrrrrrrnrrr
`K rrrrnrrsrurrrrrrrrmarrircr
`L rrnntrrrrwrrrrrrorrrrrplr
`1111111111111 ErrErarutrEnt
`htfT111111l
`N rrryrrirmrrrrrrnrrnrrtr
`o rrrurrnrrnrnnotrrrrrrrr
`P ErrrorrnrFirrrnarrrrrrar
`
`1000
`
`3503
`
`3X0
`
`I 2930
`
`1600
`
`1W3
`
`goo
`
`Raw Data
`
`Tra 629 P121
`Ta
`572 1613
`
`a
`
`gxPR
`
`114Pfq01
`
`26
`
`33
`
`36
`
`40
`
`46
`
`gt
`
`SS
`
`60
`
`65
`
`73
`
`Temparature
`
`library plates plate 6 screened against
`FIG 5 Data analysis software tools The ATm data analysis for one of the seven compound
`human thrombin Fig 4 is shown in various
`levels of detail The software used to analyze the miniaturized thermal shift assays per
`formed in 384 well plates displays the ATm values as an adjustable gradient color code shown at
`the right of the simulated 384 well
`the more negative the ATm White signifies
`the more positive the ATm Similarly the more blue the well
`plate The more red the well
`little or no change in Tm compared with control T0 The original 96 well plate of compounds was replicated four times on the 384
`the level of reproducibility of these measurements Al A13 Ii and 113 have the identical
`well assay plate in a quad format to reveal
`compound The control wells which contain only DMSO are designated as green which for this plate are wells H12 H24 P12 and
`P24 The fluorescence
`data for any well can be displayed for demonstration purposes by double clicking
`intensity versus temperature
`the right for well M23 which is compared with the data for a control P12 This compound
`on any well An example is shown at
`shows
`a ATm of 43°C and is one of the 21 hits on this plate with ATm 05°C A threedimensional bar chart
`representation of the A Tm data
`for this plate is also shown at the bottom The software was written in C+ + and runs on all Microsoft WindowsTmbased
`platforms
`
`Arm determinations for all 384 wells of the microplate thermal
`shift assay is described in the legend to Figure 5
`
`Multiligand binding events A demonstration of the effects
`of multiligand binding events on the miniaturized thermal shift
`assay appears in Table 1 Binding of the coenzyme NADP+
`and the folate mimetic methotrexate MTX to the bovine liver
`enzyme DHFR was analyzed individually as well as together
`ligands produced ATm values of 63°C
`Alone the individual
`for NADP± and 77°C for MTX which correspond to binding
`affinities of Kd = 24 AM for NADP+ and 58 nM for MTX
`at 25°C when calculated using Equation 3 The measurement
`for MTX is in agreement with those appearing in the literature
`see Table 1 Importantly when both ligands are present to
`there is a much larger increase in ATm of 181°C indi
`stabilization is to some extent
`the ligandinduced
`cating that
`is 41°C larger
`than that
`additive although the observed shift
`for the simple sum of the ATm values
`for the indi
`expected
`ligands This deviation from perfect additivity suggests
`
`gether
`
`vidual
`
`for these two ligands binding at ad
`some positive cooperativity
`jacent sites Support for this supposition comes from the struc
`for positive cooperativity of the
`tural and functional evidence
`binding of these two ligands at adjacent sites in DHFR enzymes
`from both eukaryotic and prokaryotic organisms3335 For ex
`ample a 100 fold increase in binding affinity of MTX at 10°C
`was reported when NADPH was bound to the bovine liver
`DHFR36 see Table 1
`
`DISCUSSION
`
`General drug discovery applications
`
`The successful measurements of binding affinity for assorted
`ligands binding to diverse classes of protein targets Figs 3 and
`4 demonstrate that
`the miniaturized thermal shift assay strat
`egy has wide cross target utility Of the 100 proteinligand
`complexes investigated to date only proteins with heme groups
`
`BioRad Exhibit 2008
`IPR201700055
`Page 7 of 12
`
`

`

`436
`
`Ligands
`
`None
`
`10 mM
`NADP
`NADPH 10 mM
`MTX 01 mM
`MTX
`NADP±
`
`NADPH
`
`MTX
`
`None
`
`NADPH
`MTX
`
`NADPH
`
`TABLE 1 EVALUATION
`
`BINDING USING MINIATURIZED
`OF MULTILIGAND
`BOVINE LIVER DHFR AS A TEST CASEa
`
`THERMAL
`
`SHIFT ASSAYS
`
`PANTOLIANO ET AL
`
`AT7 °C
`
`Kd nM
`
`Miniaturized Thermal Shift Data
`
`Tn = 518 ± 04
`63 ± 01
`
`97 ± 02
`
`77 ± 04
`
`181 ± 04
`= 140
`
`246 ± 06
`= 174
`
`Tn = 491
`
`82
`
`133
`
`2400
`
`810
`
`58
`
`Positive cooperativity
`Tm = +41°C >
`
`Positive cooperativity
`Tm = +72°C >
`
`DSC Data
`
`Kd nM in
`
`literature
`
`No data
`
`40 humanb
`33
`
`Positive
`
`cooperativity
`
`MTX binds 125
`fold tighter
`E colid
`
`Positive cooperativity
`MTX binds 100
`fold tighter
`Kd = 0033 nM`
`
`See ref 35
`
`See ref 35
`
`See ref 35
`
`See ref 35
`
`MTX
`
`290
`
`= 215
`
`Positive cooperativity
`= +75°C >
`
`The cooperativity of ligand binding to bovine
`
`liver DHFR was investigated
`using the miniaturized thermal shift assay Conditions employed were
`sum of individual ATn values for two ligands when present alone ie MTX
`
`the Kd for the human enzyme was reported to be 40 nM by Schweitzer
`
`50 mM HEPES pH 75 and 100 mM NaC1 in a volume of 5 t
`and NADPH under
`identical conditions
`bA Kd for NADPH binding to bovine liver DHFR could not be found however
`et al33
`
`eGilli et al36 These conditions were for bovine liver DHFR at pH 68 01 M potassium phosphate buffer at 10°C
`dCooperativity for NADPHr and MTX binding to Escherichia coil DHFR34
`Differential scanning calorimetry DSC conditions employed by Sasso et al33 were pH 68 01 M potassium phosphate buffer
`
`to yield low fluorescence as a result of quench
`were observed
`ing of the extrinsic dye fluorescence signal although this did
`not preclude using the assay at a higher concentration
`The binding affinity results obtained for the miniaturized
`thermal shift assay were found to be largely consistent with the
`fluorescence
`results obtained through enzymatic
`radioactive
`polarization isothermal
`titration calorimetry or other kinds of
`assays This was best demonstrated by the correlation between
`the continuous spectrometric enzyme assay and thermal shift
`data for the combinatorial
`libraries directed at the catalytic site
`of thrombin Fig 4
`One advantage of the miniaturized thermal shift strategy is the
`fundamental biophysical basis of the assay which circumvents
`the need to design and retool new assays for each new protein
`is that this strategy does not re
`target Another related outcome
`targets func
`quire any prior knowledge of a specific therapeutic
`tion in order to screen libraries and optimize drug leads In this
`regard the results for bacteriorhodopsin and the estrogen recep
`that the miniaturized thermal shift assay strategy will
`tor suggest
`be useful for drug discovery efforts with GECRs and nuclear hor
`
`mone receptors especially those orphan receptors for which drug
`screening presents a problem because of the lack of known lig
`ands These properties make a miniaturized thermal shift assay
`and
`ideally suited for high throughput drug screening
`strategy
`evaluation of targets derived from genomics
`
`Multiligand binding applications
`
`The data in Table 1
`illustrate the utility of the miniaturized
`thermal shift assay for assessing multiligand binding to protein
`targets The data show that this process
`can not only identify
`ligands binding to substrate binding sites of enzymes but also
`identify and judge the cooperativity of ligands binding to co
`factor allosteric andor regulatory sites on therapeutic targets
`Exosites on enzymes are often useful targets of therapeutic in
`tervention as demonstrated by the thrombin cofactor heparin
`an effective anticoagulant3738 In this regard the miniaturized
`thermal shift assay could be used in conjunction with protein
`information nuclear magnetic resonance
`flTMR1 or
`structural
`xray diffraction and be used to identify ligands binding at ad
`
`BioRad Exhibit 2008
`IPR201700055
`P

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket